With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience. As of fiscal year-end 2024, Thermo ...

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.

Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

The global Gamma Linolenic Acid (GLA) market is anticipated to reach a valuation of USD 197.2 million by 2025. With an estimated compound annual growth rate (CAGR) of 4.9%, the market is expected to ...

The Taoiseach Micheál Martin has been accused by Opposition parties of “plámásing” the US president while also drawing ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...